Advertisement
U.S. Markets closed
S&P Futures
5,885.00 -2.00 (-0.03%) Dow Futures
43,493.00 -18.00 (-0.04%) Nasdaq Futures
20,369.00 +1.00 (+0.00%) Russell 2000 Futures
2,293.60 -4.10 (-0.18%) Crude Oil
70.93 +0.26 (+0.37%) Gold
2,721.60 +14.10 (+0.52%)
FibroGen, Inc. (FGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 0.3757 |
| Open | 0.3800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.3669 - 0.3950 |
| 52 Week Range | 0.3010 - 2.9300 |
| Volume | |
| Avg. Volume | 1,745,679 |
| Market Cap | 39.658M |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7000 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.60 |
GuruFocus.comFibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
FibroGen Inc (FGEN) reports significant revenue increases and strategic pivots amid challenges in clinical trials and market competition.
Clinical Trials ArenaDuchenne muscular dystrophy: major trials and events to watch in 2023
A possible gene therapy approval and a series of major trials readouts set the stage for a busy year of drug development in Duchenne muscular dystrophy.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.